Lilly to seek industry-first FDA nod in autoimmune hair loss after Olumiant’s second trial win

Lilly to seek industry-first FDA nod in autoimmune hair loss after Olumiant’s second trial win
fkansteiner
Thu, 04/22/2021 – 11:30